(Q45285131)

English

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

scientific article published in March 2005

Statements

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study (English)
Kristian Wachtell
Mika Lehto
Eva Gerdts
Michael H Olsen
Björn Hornestam
Hans Ibsen
Stevo Julius
Lars H Lindholm
Markku S Nieminen
1 March 2005
712-719

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit